Tirzepatide dosage chart: the 2.5 to 15 mg ladder, week by week, and what each step costs

Tirzepatide starts at 2.5 mg weekly for 4 weeks, then climbs in 2.5 mg steps of at least 4 weeks to 15 mg max. The chart, the units and the cost per step.

7 min read · published Oct 2

The short version

  • 1Six weekly doses: 2.5, 5, 7.5, 10, 12.5 and 15 mg. Start at 2.5 mg for 4 weeks, then 2.5 mg steps with at least 4 weeks on each.
  • 22.5 mg is a starting dose only. The label's weight maintenance doses are 5, 10 or 15 mg; 15 mg is the maximum.
  • 3Lilly's self-pay for Zepbound climbs with the dose: $299, $399, $499, then $699 from 10 mg up.
  • 4Compounded tirzepatide is measured in units, and the units depend on your vial's concentration. Use the dose converter, not a guess.
  • 5Your prescriber sets your dose and the pace. This chart is the label's schedule, not advice.

Tirzepatide has six weekly doses, from 2.5 mg to 15 mg, and the label climbs them in 2.5 mg steps every four weeks or more. Tirzepatide is a GIP and GLP-1 receptor agonist,3 sold by Lilly as Zepbound for weight and as Mounjaro for type 2 diabetes.4 The chart below is the Zepbound label's schedule, with what each step costs.

Worth knowing

Your dose, and when you move up, are set by your prescriber. This is the manufacturer's published schedule so you know what to expect. It is not a reason to change anything yourself.

The tirzepatide dosage chart

Weekly doseLabel roleEarliest week on it
2.5 mgStarting dose only, "not approved as a maintenance dosage"1
5 mgMaintenance dose for weight5
7.5 mgStep up9
10 mgMaintenance dose for weight and sleep apnoea13
12.5 mgStep up17
15 mgMaintenance dose for weight and sleep apnoea; the maximum21

Source: Zepbound label, sections 2.1 and 2.2.1 "Earliest week" assumes every step happens at the label's four-week minimum. Many people climb slower, and nothing in the label requires climbing to the top.

The rule behind the chart

In the label's words: start at "2.5 mg injected subcutaneously once weekly for 4 weeks", then "increase the dosage to 5 mg", and after that "the dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose".1 The stated reason is "to reduce the risk of gastrointestinal adverse reactions".

Where to stop is also in the label: "Consider treatment response and tolerability when selecting the maintenance dosage. If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage." For weight the maintenance doses are 5, 10 or 15 mg; for obstructive sleep apnoea, 10 or 15 mg. The maximum is 15 mg once weekly.1

In plain English

Mounjaro is the same molecule, and Lilly's Mounjaro site reports results at 5 mg and 15 mg.4 The schedule quoted on this page is from the Zepbound label. If you take Mounjaro for diabetes, its own label and your prescriber govern your doses.

What the doses did in the trial

SURMOUNT-1 tested three maintenance doses for 72 weeks. Mean weight change was −15.0% at 5 mg, −19.5% at 10 mg and −20.9% at 15 mg, against −3.1% on placebo.5 The step from 5 to 10 mg added 4.5 points; the step from 10 to 15 mg added 1.4. The 7.5 and 12.5 mg doses were steps, not trial arms. Per-dose side effects are in Zepbound side effects.

What each step costs

On the brand, the dose sets the cash price. Lilly's self-pay for a Zepbound vial or KwikPen is $299 a month at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg.6 With a commercial plan that covers Zepbound, Lilly's card brings it to "as low as $25" at any dose.6 Here is Lilly's ladder next to the cheapest verified Zepbound seller today:

Compounded tirzepatide costs less. Some sellers hold one price at every dose and others charge more as you climb, so ask which before you pay. Today's verified prices, all in:

Compounded tirzepatide: doses in units

Compounded vials are drawn with an insulin syringe, so the dose your prescriber writes in milligrams becomes units on the syringe. How many units depends on the concentration of your vial, in mg per mL, which differs between pharmacies. The same milligram dose can be a different number of units from one vial to the next.

Use the GLP-1 dose converter: enter your dose and the concentration printed on your vial, and it gives mL and U-100 units. The arithmetic it uses is your dose in mg divided by the mg per mL, times 100. If the units on your pharmacy's instructions do not match, ask the pharmacy before you inject.

Worth knowing

FDA has received reports of adverse events "that may be related to dosing errors" with compounded semaglutide injections, and reports tied to compounded semaglutide or tirzepatide "in doses beyond what is in the FDA-approved drug label".7 Compounded drugs "are not FDA-approved", and FDA "does not verify the safety, effectiveness or quality" of them before they are sold.8

Missed doses and storage

The Zepbound label: if a dose is missed, "administer within 4 days (96 hours) after the missed dose". If more time has passed, ask your prescriber what to do. A single-dose pen or vial can be kept out of the fridge, at up to 30°C (86°F), "for up to a total of 21 days".2 Compounded vials follow their pharmacy's instructions.

The honest summary

Four weeks at 2.5 mg, then 2.5 mg steps of at least four weeks each, stopping at the dose your prescriber and your tolerance settle on, with 15 mg the ceiling. On Lilly's self-pay prices each step up to 10 mg raises the bill; compounded sellers are cheaper and vary in whether they charge by dose. If you are on a compounded vial, get the units from the dose converter and your vial's label, every time the vial changes.

Sources8
  1. Zepbound prescribing information (DailyMed), sections 2.1 and 2.2 read Sep 3“The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks. The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. Follow the dosage escalation below for all indications to reduce the risk of gastrointestinal adverse reactions ... After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly. The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose ... Consider treatment response and tolerability when selecting the maintenance dosage. If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage. ... Weight Reduction and Long-Term Maintenance The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly. OSA The recommended maintenance dosage is 10 mg or 15 mg injected subcutaneously once weekly. ... Maximum Recommended Dosage: 15 mg injected subcutaneously once weekly.” ↩
  2. Zepbound prescribing information, section 3 and 16, forms and storage read Sep 3“pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths. The multi-dose vials and single-patient-use KwikPen each contain 4 doses: Single-dose Pen or Vial 2.5 mg/0.5 mL 5 mg/0.5 mL 7.5 mg/0.5 mL 10 mg/0.5 mL 12.5 mg/0.5 mL 15 mg/0.5 mL Multi-dose Vial (4 doses per vial) Dose per Injection Total Strength per Total Volume Strength per mL 2.5 mg/0.6 mL 10 mg/2.4 mL 4.17 mg/mL 5 mg/0.6 mL 20 mg/2.4 mL 8.33 mg/mL 7.5 mg/0.6 mL 30 mg/2.4 mL 12.5 mg/mL 10 mg/0.6 mL 40 mg/2.4 mL 16.7 mg/mL 12.5 mg/0.6 mL 50 mg/2.4 mL 20.8 mg/mL ... If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days. ... If a dose is missed, administer within 4 days (96 hours) after the missed dose.” ↩
  3. Zepbound prescribing information (DailyMed), description read Sep 3“ZEPBOUND (tirzepatide) injection, for subcutaneous use, contains tirzepatide, a GIP receptor and GLP-1 receptor agonist. ... The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks.” ↩
  4. Mounjaro.lilly.com, what Mounjaro is for read Sep 3“along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus. ... to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes mellitus who are at high risk for these events. ... Mounjaro is not a weight loss drug. ... In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).” ↩
  5. Jastreboff et al., SURMOUNT-1, NEJM 2022 read Sep 3“The mean percentage change in weight at week 72 was -15.0% (95% confidence interval [CI], -15.9 to -14.2) with 5-mg weekly doses of tirzepatide, -19.5% (95% CI, -20.4 to -18.5) with 10-mg doses, and -20.9% (95% CI, -21.8 to -19.9) with 15-mg doses and -3.1% (95% CI, -4.3 to -1.9) with placebo” ↩
  6. Eli Lilly, Zepbound cost information read Sep 2“The list price of Zepbound is $499 - $1,086.37 per fill, but the amount you pay will largely depend on your prescription drug insurance plan. ... Available through Zepbound self-pay, Zepbound is offered as a 4‑count single‑dose vial (0.5mL) and a single‑patient‑use KwikPen (2.4mL, 0.6mL/dose) in doses of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, with direct‑to‑patient pricing of $299, $399, $499, $699, $699 and $699 respectively. ... If you have commercial drug insurance with coverage for Zepbound, you may be eligible to pay as low as $25 for a one- or three-month supply Zepbound single-dose pens.” ↩
  7. FDA, concerns with unapproved GLP-1 drugs used for weight loss read Sep 3“unapproved versions do not undergo FDA's review for safety, effectiveness and quality before they are marketed. ... FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products. ... the agency has received adverse event reports that may be related to patients prescribed compounded semaglutide or tirzepatide products in doses beyond what is in the FDA-approved drug label.” ↩
  8. FDA, Compounding and the FDA: Questions and Answers read Sep 3“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” ↩

Common questions

What is the tirzepatide dosing schedule?

The Zepbound label starts at 2.5 mg once weekly for 4 weeks, then 5 mg. After that the dose may rise in 2.5 mg steps with at least 4 weeks on each, up to 15 mg. Your prescriber decides whether and when you move up.

What is the maximum dose of tirzepatide?

15 mg once weekly, per the Zepbound label. The label's maintenance doses for weight are 5, 10 or 15 mg, and 10 or 15 mg for sleep apnoea.

Can you stay on 2.5 mg of tirzepatide?

Not as a maintenance dose under the label, which says 2.5 mg is for starting treatment and is not approved for maintenance. The lowest labelled maintenance dose is 5 mg.

How many units of compounded tirzepatide is my dose?

It depends on your vial's concentration in mg per mL. Divide your dose in mg by that concentration and multiply by 100 for U-100 syringe units, or enter both into our dose converter. Check the result against your pharmacy's instructions.

How much does each tirzepatide dose cost?

Lilly's Zepbound self-pay is $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10 mg and above. With commercial coverage, Lilly's card can bring it to $25. Compounded tirzepatide costs less; the live board shows today's prices.

What if I miss a dose?

The Zepbound label says to take it within 4 days (96 hours) of the missed dose. If more time has passed, ask your prescriber before your next injection.

Read next